These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 6339220

  • 21. [The history and the present conditions of the occupational bladder cancer in our country].
    Matsushima M, Kuwabara T.
    Nihon Hinyokika Gakkai Zasshi; 2013 Jul; 104(4):569-78. PubMed ID: 23971365
    [Abstract] [Full Text] [Related]

  • 22. Bladder cancer: a selected review of the epidemiological literature.
    Pirastu R, Iavarone I, Comba P.
    Ann Ist Super Sanita; 1996 Jul; 32(1):3-20. PubMed ID: 8967723
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Bladder cancer as a prescribed industrial disease: a guide for clinicians.
    Somerville SM, Davies JM, Hendry WF, Williams G.
    Br Med J; 1980 Feb 23; 280(6213):540-2. PubMed ID: 6445219
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Monitoring of laborers previously exposed to aromatic amines, in accordance with Circulars No. 46 of 12/6/1979 and No. 61 of 4/6/1981 of the Ministry of Labor].
    Seghizzi P, Cassina G, Malinverni C, Mosconi G, Belotti L, Musitelli O, Ghisi R.
    G Ital Med Lav; 1983 Sep 23; 5(5):207-13. PubMed ID: 6680374
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Risk factors for bladder cancer in a cohort exposed to aromatic amines.
    Schulte PA, Ringen K, Hemstreet GP, Altekruse EB, Gullen WH, Tillett S, Allsbrook WC, Crosby JH, Witherington R, Stringer W.
    Cancer; 1986 Nov 01; 58(9):2156-62. PubMed ID: 3756832
    [Abstract] [Full Text] [Related]

  • 35. Risk assessment of a cohort exposed to aromatic amines. Initial results.
    Schulte PA, Ringen K, Hemstreet GP, Altekruse EB, Gullen WH, Patton MG, Allsbrook WC, Crosby JH, West SS, Witherington R.
    J Occup Med; 1985 Feb 01; 27(2):115-21. PubMed ID: 3884754
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Acetylation phenotype as a biomarker of sensitivity to the carcinogenic effect of aromatic amines].
    Indulski JA, Krajewska B, Lutz W.
    Med Pr; 1992 Feb 01; 43(5):427-35. PubMed ID: 1293477
    [Abstract] [Full Text] [Related]

  • 38. Epidemiology and etiology of human bladder cancer: occupational bladder cancer in the British rubber industry.
    Parkes HG.
    J Natl Cancer Inst; 1969 Jul 01; 43(1):249-52. PubMed ID: 5796387
    [No Abstract] [Full Text] [Related]

  • 39. [Usefulness of biological tumor markers for early detection of neoplastic changes in the bladder of persons exposed to aromatic amines].
    Hanke J, Krajewska B, Lutz W.
    Med Pr; 1989 Jul 01; 40(6):376-80. PubMed ID: 2698439
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.